SIGN UP FOR GH891 – Global Pharmaceutical Policy: At the Intersection of Process and Politics
STEP UP TO THE PLATE AND SIGN UP FOR GH891 (SPRING 2016)
WHY IS ACCESS TO OPIATES SUCH A DIFFICULT PHARMACEUTICAL POLICY PROBLEM?
WHY SHOULD COUNTRIES IN AFRICA BOTHER MAKING THEIR OWN MEDICINES?
DO YOU THINK THE FDA SHOULD REGULATE E-CIGARETTES?
HAVE YOU EVER TESTIFIED BEFORE A SENATE SUBCOMMITTEE?
A wide range of challenges face policy makers in the pharmaceutical sector, from the role of citizen participation in decision-making to regulation of opioids and pain killers to deciding on the most appropriate way of regulating, if at all, ‘new technologies’ such as electronic cigarettes. Quite often, in the United States and elsewhere, pro-public health policies may meet a certain degree of political and interest group resistance.
This course is intended to introduce the student to the ‘real world’ of pharmaceutical policy making in global health. The course introduces students to global pharmaceutical policies with specific examples as case studies and group exercises . The case studies in the course will be updated year-to-year to introduce current and controversial issues. The intention is to build on the models and methods covered in “Pharmaceuticals in Public Health” (PH 740) and apply these approaches to specific pharmaceutical policy issues.
This course will assist students who later find employment in national administrations, government agencies, and other bodies that deal with pharmaceuticals on a regular or occasional basis and/or as staff members and consultants of global organizations, health sector nongovernmental organizations, and other health projects with a pharmaceutical component. Students who intend to work within the pharmaceutical industry will also benefit, particularly if they aspire to work in Government Affairs or Business Development departments.
